<DOC>
	<DOCNO>NCT02237534</DOCNO>
	<brief_summary>The purpose study compare effect lanthanum carbonate calcium carbonate progression coronary calcification vascular endothelial dysfunction .</brief_summary>
	<brief_title>Lanthanum Versus Calcium Carbonate Vascular Abnormalities Patients With CKD Hyperphosphatemia</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Hyperphosphatemia</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Calcium Carbonate</mesh_term>
	<criteria>Hyperphosphatemia ( For patient without calcium carbonate , ≥4.5 mg/dL ) ( For patient calcium carbonate , ≥4.0 mg/dL ) With write informed consent History cardiac surgery With coronary artery stent Polycystic kidney disease Hypothyroidism On treatment lanthanum carbonate History admission within 3 month History ileus Severe liver dysfunction Severe gastrointestinal dysfunction Allergy lanthanum carbonate calcium carbonate Pregnant breastfeed woman Judged ineligible investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Lanthanum</keyword>
	<keyword>Calcium Carbonate</keyword>
	<keyword>Vascular Calcification</keyword>
</DOC>